Medical Editor: John P. Cunha, DO, FACOEP
Beconase AQ (beclomethasone nasal) is a steroid used to treat nasal symptoms such as congestion, sneezing, and runny nose caused by seasonal or year-round allergies. Beconase AQ is also used to keep nasal polyps from coming back after surgery to remove them. The brand name Beconase AQ is discontinued, but generic versions may be available. Common side effects of Beconase AQ (beclomethasone nasal) include sneezing, runny or stuffy nose, dryness or irritation in your nose or throat, nausea, headache, feeling light-headed, unpleasant taste or smell, itching or rash, or sores or white patches inside or around your nose.
The usual dosage of Beconase AQ for adults and children 12 and older is 1 or 2 nasal inhalations (42 to 84 mcg) in each nostril twice a day (total dose, 168 to 336 mcg/day). Other drugs may interact with Beconase AQ nasal. Tell your doctor all prescription and over-the-counter medications and supplements you use. During pregnancy, Beconase AQ should be used only when prescribed. Doctors may consider this drug to be safe to use during pregnancy. Rarely, infants born to mothers who have been using corticosteroids may have low levels of corticosteroid hormone. Tell your doctor if you notice symptoms such as persistent nausea/vomiting, severe diarrhea, or weakness in your newborn. It is unknown if this drug passes into breast milk. Similar drugs pass into breast milk. Consult your doctor before breastfeeding.
Our Beconase AQ (beclomethasone dipropionate, monohydrate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
- severe or ongoing nose bleed;
- sores in the nose that won't heal;
- wheezing, trouble breathing;
- blurred vision, eye pain, or seeing halos around lights; or
- fever, chills, body aches, flu symptoms.
Less serious side effects may include:
- sneezing, runny or stuffy nose;
- dryness or irritation in your nose or throat;
- nausea, headache, feeling light-headed;
- unpleasant taste or smell;
- mild itching or rash; or
- sores or white patches inside or around your nose.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Beconase-AQ (Beclomethasone Dipropionate, Monohydrate)
Adverse reactions reported in controlled clinical trials and open studies in patients treated with BECONASE AQ Nasal Spray are described below.
Mild nasopharyngeal irritation following the use of beclomethasone aqueous nasal spray has been reported in up to 24% of patients treated, including occasional sneezing attacks (about 4%) occurring immediately following use of the spray. In patients experiencing these symptoms, none had to discontinue treatment. The incidence of transient irritation and sneezing was approximately the same in the group of patients who received placebo in these studies, implying that these complaints may be related to vehicle components of the formulation.
Fewer than 5 per 100 patients reported headache, nausea, or lightheadedness following the use of BECONASE AQ Nasal Spray. Fewer than 3 per 100 patients reported nasal stuffiness, nosebleeds, rhinorrhea, or tearing eyes.
Reports of dryness and irritation of the nose and throat and unpleasant taste and smell have been received. There are rare reports of loss of taste and smell.
Rare cases of immediate and delayed hypersensitivity reactions, including anaphylactoid/anaphylactic reactions, urticaria, angioedema, rash, and bronchospasm, have been reported following the oral and intranasal inhalation of beclomethasone dipropionate.
Cases of growth suppression have been reported for intranasal corticosteroids, including BECONASE AQ (see PRECAUTIONS: Pediatric Use).
Read the entire FDA prescribing information for Beconase-AQ (Beclomethasone Dipropionate, Monohydrate)
© Beconase-AQ Patient Information is supplied by Cerner Multum, Inc. and Beconase-AQ Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.